BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed CRBP catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:34d1a74e2620ab07d111@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270116
DTEND;VALUE=DATE:20270117
SUMMARY:CRBP P1/P2 readout (est.): A Phase 1/2 Study to Investigate CRB-701
  in Solid Tumors
DESCRIPTION:A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors\nNCT06
 265727 | PHASE1/PHASE2 | RECRUITING | sponsor: Corbus Pharmaceuticals Inc.
 \nPrimary completion date (ESTIMATED)\; top-line results usually follow la
 ter.\nTicker CRBP (confidence 0.9)\nSource: https://clinicaltrials.gov/stu
 dy/NCT06265727\nScheduling/reference data from public records\; dates can 
 move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06265727
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
